Tirzepatide is a customized treatment created for Willow patients who require a more tailored approach to GLP-1/GIP therapy. Designed for those whose health profiles or goals require clinical personalization, this compounded formulation is developed in collaboration with your Willow physician as part of your individualized care plan.


At its core is Tirzepatide, a next-generation dual agonist that targets both GLP-1 and GIP receptors to help regulate appetite, support metabolic balance, and drive meaningful weight loss. To match your unique physiology and treatment goals, your formulation may also include supportive ingredients like Cyanocobalamin (Vitamin B12) to boost energy, or L-Carnitine to aid fat metabolism and muscle preservation.



Every dose is compounded with your specific needs in mind—offering a personalized path to sustainable weight loss and overall well-being. This isn’t a standard treatment; it’s one made just for you.
Because your journey is personal—and your medication should be too.